Brian Corvese - Mar 25, 2024 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
PTIX
Transactions as of
Mar 25, 2024
Transactions value $
$76,125
Form type
4
Date filed
3/29/2024, 09:29 PM
Previous filing
Mar 5, 2024
Next filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock Options Award $76.1K +43.8K $1.74 43.8K Mar 25, 2024 PTIX Common Stock, Par Value $0.0001 43.8K $1.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The options vest monthly over 24 months, commencing upon the date of grant, with full acceleration upon a change of control.